Segura, E. Human dendritic cell subsets: An updated view of their ontogeny and functional specialization. Eur. J. Immunol. 2022,
52, 1759–1767.
Giza, H.M.; Bozzacco, L. Unboxing dendritic cells: Tales of multi-faceted biology and function. Immunology 2021, 164, 433–449.
Eisenbarth, S.C. Dendritic cell subsets in T cell programming: Location dictates function. Nat. Rev. Immunol. 2019, 19, 89–103.
4. Boardman, D.A.; Jacob, J.; Smyth, L.A.; Lombardi, G.; Lechler, R.I. What Is Direct Allorecognition? Curr. Transplant. Rep. 2016, 3,
275–283.
5. Lechler, R.I.; Batchelor, J.R. Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor
strain dendritic cells. J. Exp. Med. 1982, 155, 31–41.
6. Liu, Z.; Braunstein, N.S.; Suciu-Foca, N. T cell recognition of allopeptides in context of syngeneic MHC. J. Immunol. 1992, 148,
35–40.
7. Benichou, G.; Takizawa, P.A.; Olson, C.A.; McMillan, M.; Sercarz, E.E. Donor major histocompatibility complex (MHC) peptides
are presented by recipient MHC molecules during graft rejection. J. Exp. Med. 1992, 175, 305–308.
8. Smyth, L.A.; Lechler, R.I.; Lombardi, G. Continuous Acquisition of MHC:Peptide Complexes by Recipient Cells Contributes to
the Generation of Anti-Graft CD8+ T Cell Immunity. Am. J. Transplant. 2017, 17, 60–68.
9. Benichou, G.;Wang, M.; Ahrens, K.; Madsen, J.C. Extracellular vesicles in allograft rejection and tolerance. Cell. Immunol. 2020,
349, 104063.
10. Li, B.; Lu, C.; Oveissi, S.; Song, J.; Xiao, K.; Zanker, D.; Duan, M.; Chen, J.; Xu, H.; Zou, Q.; et al. Host CD8α+ and CD103+
dendritic cells prime transplant antigen-specific CD8+ T cells via cross-dressing. Immunol. Cell Biol. 2020, 98, 563–576.
11. Hughes, A.D.; Zhao, D.; Dai, H.; Abou-Daya, K.I.; Tieu, R.; Rammal, R.; Williams, A.L.; Landsittel, D.P.; Shlomchik, W.D.; Morelli,
A.E.; et al. Cross-dressed dendritic cells sustain effector T cell responses in islet and kidney allografts. J. Clin. Investig. 2020, 130,
287–294.
12. Henry, E.; Desmet, C.J.; Garzé, V.; Fiévez, L.; Bedoret, D.; Heirman, C.; Faisca, P.; Jaspar, F.J.; Gosset, P.; Jacquet, A.P.A.; et al.
Dendritic cells genetically engineered to express IL-10 induce long-lasting antigen-specific tolerance in experimental asthma. J.
Immunol. 2008, 181, 7230–7242.
13. Taner, T.; Hackstein, H.; Wang, Z.; Morelli, A.E.; Thomson, A.W. Rapamycin-treated, alloantigen-pulsed host dendritic cells
induce ag-specific T cell regulation and prolong graft survival. Am. J. Transplant. 2005, 5, 228–236.
14. Lee, J.-H.; Park, C.-S.; Jang, S.; Kim, J.-W.; Kim, S.-H.; Song, S.; Kim, K.; Lee, C.-K. Tolerogenic dendritic cells are efficiently
generated using minocycline and dexamethasone. Sci. Rep. 2017, 7, 15087.
15. Smyth, L.A.; Ratnasothy, K.; Moreau, A.; Alcock, S.; Sagoo, P.; Meader, L.; Tanriver, Y.; Buckland, M.; Lechler, R.; Lombardi, G.
Tolerogenic Donor-Derived Dendritic Cells Risk Sensitization In Vivo owing to Processing and Presentation by Recipient APCs. J.
Immunol. 2013, 190, 4848–4860.
16. Bhatt, S.; Qin, J.; Bennett, C.; Qian, S.; Fung, J.J.; Hamilton, T.A.; Lu, L. All-trans retinoic acid induces arginase-1 and inducible
nitric oxide synthase-producing dendritic cells with T cell inhibitory function. J. Immunol. 2014, 192, 5098–5108.
17. Buckland, M.; Jago, C.B.; Fazekasova, H.; Scott, K.; Tan, P.H.; George, A.J.T.; Lechler, R.; Lombardi, G. Aspirin-treated human
DCs up-regulate ILT-3 and induce hyporesponsiveness and regulatory activity in responder T cells. Am. J. Transplant. 2006, 6,
2046–2059.
18. Song, S.-S.; Yuan, P.-F.; Chen, J.-Y.; Fu, J.-J.; Wu, H.-X.; Lu, J.T.; Wei, W. TGF-β favors bone marrow-derived dendritic cells to
acquire tolerogenic properties. Immunol. Investig. 2014, 43, 360–369.
19. Moreau, A.; Vandamme, C.; Segovia, M.; Devaux, M.; Guilbaud, M.; Tilly, G.; Jaulin, N.; Le Duff, J.; Cherel, Y.; Deschamps, J.-Y.;
et al. Generation and in vivo evaluation of IL10-treated dendritic cells in a nonhuman primate model of AAV-based gene transfer.
Mol. Ther. Methods Clin. Dev. 2014, 1, 14028.
20. Liu, X.; Sun, Y.; Zheng, Y.; Zhang, M.; Jin, X.; Kang, K.; Wang, Y.; Li, S.; Zhang, H.; Zhao, Q.; et al. Administration of Interleukin-
35-Conditioned Autologous Tolerogenic Dendritic Cells Prolong Allograft Survival After Heart Transplantation. Cell. Physiol.
Biochem. 2018, 49, 1180–1196.
21. Morante-Palacios, O.; Fondelli, F.; Ballestar, E.; Martínez-Cáceres, E.M. Tolerogenic Dendritic Cells in Autoimmunity and
Inflammatory Diseases. Trends Immunol. 2021, 42, 59–75.
22. Suuring, M.; Moreau, A. Regulatory Macrophages and Tolerogenic Dendritic Cells in Myeloid Regulatory Cell-Based Therapies.
Int. J. Mol. Sci. 2021, 22, 7970.
23. Hill, M.; Thebault, P.; Segovia, M.; Louvet, C.; Bériou, G.; Tilly, G.; Merieau, E.; Anegon, I.; Chiffoleau, E.; Cuturi, M.-C. Cell
therapy with autologous tolerogenic dendritic cells induces allograft tolerance through interferon-gamma and epstein-barr
virus-induced gene 3. Am. J. Transplant. 2011, 11, 2036–2045.
24. Sawitzki, B.; Harden, P.N.; Reinke, P.; Moreau, A.; Hutchinson, J.A.; Game, D.S.; Tang, Q.; Guinan, E.C.; Battaglia, M.; Burlingham,
W.J.; et al. Regulatory cell therapy in kidney transplantation (The ONE Study): A harmonised design and analysis of seven
non-randomised, single-arm, phase 1/2A trials. Lancet 2020, 395, 1627–1639.
25. Moreau, A.; Kervella, D.; Bouchet-Delbos, L.; Braudeau, C.; Saïagh, S.; Guérif, P.; Limou, S.; Moreau, A.; Bercegeay, S.; Streitz, M.;
et al. A Phase I/IIa study of autologous tolerogenic dendritic cells immunotherapy in kidney transplant recipients. Kidney Int.
2023, 103, 627–637.
26. Castenmiller, C.; Keumatio-Doungtsop, B.-C.; van Ree, R.; de Jong, E.C.; van Kooyk, Y. Tolerogenic Immunotherapy: Targeting
DC Surface Receptors to Induce Antigen-Specific Tolerance. Front. Immunol. 2021, 12, 643240.
27. Tanriver, Y.; Ratnasothy, K.; Bucy, R.P.; Lombardi, G.; Lechler, R. Targeting MHC class I monomers to dendritic cells inhibits the
indirect pathway of allorecognition and the production of IgG alloantibodies leading to long-term allograft survival. J. Immunol.
2010, 184, 1757–1764.
28. Yamazaki, S.; Dudziak, D.; Heidkamp, G.F.; Fiorese, C.; Bonito, A.J.; Inaba, K.; Nussenzweig, M.C.; Steinman, R.M. CD8+ CD205+
splenic dendritic cells are specialized to induce Foxp3+ regulatory T cells. J. Immunol. 2008, 181, 6923–6933.
29. Lübbers, J.; Rodríguez, E.; van Kooyk, Y. Modulation of Immune Tolerance via Siglec-Sialic Acid Interactions. Front. Immunol.
2018, 9, 2807.
30. Crocker, P.R.; Paulson, J.C.; Varki, A. Siglecs and their roles in the immune system. Nat. Rev. Immunol. 2007, 7, 255–266.
31. Macauley, M.S.; Crocker, P.R.; Paulson, J.C. Siglec-mediated regulation of immune cell function in disease. Nat. Rev. Immunol.
2014, 14, 653–666.
32. Keumatio Doungtsop, B.-C.; Nardini, E.; Kalay, H.; Versteeg, S.A.; Lübbers, J.; van Barneveld, G.; Li, E.R.J.; van Vliet, S.J.; van Ree,
R.; de Jong, E.C.; et al. Sialic acid-modified der p 2 allergen exerts immunomodulatory effects on human PBMCs. J. Allergy Clin.
Immunol. Glob. 2024, 3, 100193.
33. Pillai, S.; Netravali, I.A.; Cariappa, A.; Mattoo, H. Siglecs and immune regulation. Annu. Rev. Immunol. 2012, 30, 357–392.
34. Borges, T.J.; Lima, K.; Gassen, R.B.; Liu, K.; Ganchiku, Y.; Ribas, G.T.; Liao, M.; Goncalves, J.I.B.; Lape, I.T.; Rosales, I.A.; et al. The
inhibitory receptor Siglec-E controls antigen-presenting cell activation and T cell-mediated transplant rejection. Sci. Transl. Med.
2025, 17, eads2694.
35. Loschko, J.; Heink, S.; Hackl, D.; Dudziak, D.; Reindl,W.; Korn, T.; Krug, A.B. Antigen targeting to plasmacytoid dendritic cells
via Siglec-H inhibits Th cell-dependent autoimmunity. J. Immunol. 2011, 187, 6346–6356.
36. Perdicchio, M.; Ilarregui, J.M.; Verstege, M.I.; Cornelissen, L.A.M.; Schetters, S.T.T.; Engels, S.; Ambrosini, M.; Kalay, H.; Veninga,
H.; den Haan, J.M.M.; et al. Sialic acid-modified antigens impose tolerance via inhibition of T-
37. Bax, M.; Unger,W.; Kaur Singh, S.; McKenzie, E.J.; Litjens, M.; Garcia-Vallejo, J.J.; Saeland, E.; van Vliet, S.J.; Crocker, P.R.; van
Kooyk, Y. Targeting siglec-E on murine dendritic cells inhibits antigen presentation and CD4 and CD8 t cell responses. Ann.
Rheum. Dis. 2010, 69, A42.
38. Honjo, K.; Yan Xu, X.; Kapp, J.A.; Bucy, R.P. Evidence for cooperativity in the rejection of cardiac grafts mediated by CD4 TCR Tg
T cells specific for a defined allopeptide. Am. J. Transplant. 2004, 4, 1762–1768.
39. Brennan, T.V.; Jaigirdar, A.; Hoang, V.; Hayden, T.; Liu, F.-C.; Zaid, H.; Chang, C.K.; Bucy, R.P.; Tang, Q.; Kang, S.-M. Preferential
priming of alloreactive T cells with indirect reactivity. Am. J. Transplant. 2009, 9, 709–718.
40. Wang, J.; Manni, M.; Bärenwaldt, A.; Wieboldt, R.; Kirchhammer, N.; Ivanek, R.; Stanczak, M.; Zippelius, A.; König, D.; Rodrigues
Manutano, N.; et al. Siglec Receptors Modulate Dendritic Cell Activation and Antigen Presentation to T Cells in Cancer. Front.
Cell Dev. Biol. 2022, 10, 828916.
41. Angata, T.; Hingorani, R.; Varki, N.M.; Varki, A. Cloning and characterization of a novel mouse Siglec, mSiglec-F: Differential
evolution of the mouse and human (CD33) Siglec-3-related gene clusters. J. Biol. Chem. 2001, 276, 45128–45136.
42. Ding, Y.; Guo, Z.; Liu, Y.; Li, X.; Zhang, Q.; Xu, X.; Gu, Y.; Zhang, Y.; Zhao, D.; Cao, X. The lectin Siglec-G inhibits dendritic cell
cross-presentation by impairing MHC class I-peptide complex formation. Nat. Immunol. 2016, 17, 1167–1175.
43. Hildner, K.; Edelson, B.T.; Purtha,W.E.; Diamond, M.; Matsushita, H.; Kohyama, M.; Calderon, B.; Schraml, B.U.; Unanue, E.R.;
Diamond, M.S.; et al. Batf3 deficiency reveals a critical role for CD8α+ dendritic cells in cytotoxic T cell immunity. Science 2008,
322, 1097–1100.
44. Mayer, C.T.; Ghorbani, P.; Nandan, A.; Dudek, M.; Arnold-Schrauf, C.; Hesse, C.; Berod, L.; Stüve, P.; Puttur, F.; Merad, M.; et al.
Selective and efficient generation of functional Batf3-dependent CD103+ dendritic cells from mouse bone marrow. Blood 2014,
124, 3081–3091.
45. Naik, S.H.; Sathe, P.; Park, H.-Y.; Metcalf, D.; Proietto, A.I.; Dakic, A.; Carotta, S.; O’Keeffe, M.; Bahlo, M.; Papenfuss, A.; et al.
Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo.
Nat. Immunol. 2007, 8, 1217–1226.
46. Marín, E.; Cuturi, M.C.; Moreau, A. Tolerogenic Dendritic Cells in Solid Organ Transplantation: Where Do We Stand? Front.
Immunol. 2018, 9, 274.
47. Bain, C.C.; Montgomery, J.; Scott, C.L.; Kel, J.M.; Girard-Madoux, M.J.H.; Martens, L.; Zangerle-Murray, T.F.P.; Ober-Blöbaum, J.;
Lindenbergh-Kortleve, D.; Samsom, J.N.; et al. TGFβR signalling controls CD103+CD11b+ dendritic cell development in the
intestine. Nat. Commun. 2017, 8, 620.
48. Tateyama, H.; Murase, Y.; Higuchi, H.; Inasaka, Y.; Kaneoka, H.; Iijima, S.; Nishijima, K. Siglec-F is induced by granulocyte–
macrophage colony-stimulating factor and enhances interleukin-4-induced expression of arginase-1 in mouse macrophages.
Immunology 2019, 158, 340–352.
49. Idoyaga, J.; Fiorese, C.; Zbytnuik, L.; Lubkin, A.; Miller, J.; Malissen, B.; Mucida, D.; Merad, M.; Steinman, R.M. Specialized role of
migratory dendritic cells in peripheral tolerance induction. J. Clin. Investig. 2013, 123, 844–854.
50. Li, R.-J.E.; de Haas, A.; Rodríguez, E.; Kalay, H.; Zaal, A.; Jimenez, C.R.; Piersma, S.R.; Pham, T.V.; Henneman, A.A.; de Goeij-de
Haas, R.R.; et al. Quantitative Phosphoproteomic Analysis Reveals Dendritic Cell- Specific STAT Signaling After α2-3-Linked
Sialic Acid Ligand Binding. Front. Immunol. 2021, 12, 673454.
51. Lübbers, J.; Eveline Li, R.-J.; Gorki, F.S.; Bruijns, S.C.M.; Gallagher, A.; Kalay, H.; Ambrosini, M.; Molenaar, D.; Van den Bossche,
J.; van Vliet, S.J.; et al. α2-3 Sialic acid binding and uptake by human monocyte-derived dendritic cells alters metabolism and
cytokine release and initiates tolerizing T cell programming. Immunother. Adv. 2021, 1, ltab012.